Thrombotic Microangiopathy and Renal Failure Exacerbated by ε-Aminocaproic Acid

American Journal of Kidney Diseases

Volumn 53, Issue 2, 2009, Pages 346-350

  Mutter, Walter P ^a   Stillman, Isaac E ^a   Dahl, Neera K ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lunate aminocaproic acid; Amicar; antiphospholipid antibodies; antiphospholipid syndrome; antiphospholipid syndrome nephropathy; hemolytic anemia; renal failure; systemic lupus erythematosus; Thrombotic microangiopathy

Indexed keywords

ACETYLSALICYLIC ACID; AMINOACPROIC ACID EPSILON; AMINOCAPROIC ACID; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON MICROSCOPY; FEMALE; FIBRINOLYSIS; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; KIDNEY BIOPSY; KIDNEY FAILURE; LOADING DRUG DOSE; MICROSCOPY; PHYSICAL EXAMINATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 58249136318     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.07.023     Document Type: Article

References (21)

1. Frederiksen M.C., Bowsher D.J., Ruo T.I., et al. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther 35 (1984) 387-393
2. Manjunath G., Fozailoff A., Mitcheson D., and Sarnak M.J. Epsilon-aminocaproic acid and renal complications: Case report and review of the literature. Clin Nephrol 58 (2002) 63-67
3. Humphreys B.D., Sharman J.P., Henderson J.M., et al. Gemcitabine-associated thrombotic microangiopathy. Cancer 100 (2004) 2664-2670
4. Ruggenenti P., Noris M., and Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60 (2001) 831-846
5. Ponticelli C., and Banfi G. Thrombotic microangiopathy after kidney transplantation. Transpl Int 19 (2006) 789-794
6. Qu L., and Kiss J.E. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost 31 (2005) 691-699
7. Ardalan M.R. Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA. Saudi J Kidney Dis Transpl 17 (2006) 235-244
8. Harris E.N., Chan J.K., Asherson R.A., Aber V.R., Gharavi A.E., and Hughes G.R. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 146 (1986) 2153-2156
9. Hughes G.R., Harris N.N., and Gharavi A.E. The anticardiolipin syndrome. J Rheumatol 13 (1986) 486-489
10. Rosove M.H., and Brewer P.M. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117 (1992) 303-308
11. Khamashta M.A., Cuadrado M.J., Mujic F., Taub N.A., Hunt B.J., and Hughe G.R. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332 (1995) 993-997
12. Erkan D., Yazici Y., Peterson M.G., Sammaritano L., and Lockshin M.D. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 41 (2002) 924-929
13. Jain R., Chartash E., Susin M., and Furie R. Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 24 (1994) 173-182
14. Espinosa G., Bucciarelli S., Cervera R., et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 63 (2004) 730-736
15. Nesher G., Hanna V.E., Moore T.L., Hersh M., and Osborn T.G. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 24 (1994) 165-172
16. Kozmin L.D., Shirokova I.E., Lisitsina T.A., et al. Anti-plasminogen autoantibodies from plasma of patients with systemic lupus erythematosus having anti-phospholipid antibody syndrome: Isolation and some immunochemical properties. Biochemistry (Mosc) 68 (2003) 339-345
17. Nochy D., Daugas E., Hill G., and Piette J.C. [Anti-phospholipid syndrome nephropathy]. Ann Med Interne (Paris) 154 (2003) 51-58
18. Tektonidou M.G., Sotsiou F., Nakopoulou L., Vlachoyiannopoulos P.G., and Moutsopoulos H.M. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50 (2004) 2569-2579
19. Daugas E., Nochy D., Huong D.L., et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13 (2002) 42-52
20. Nochy D., Daugas E., Droz D., et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10 (1999) 507-518
21. Moroni G., Ventura D., Riva P., et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43 (2004) 28-36